These emerging treatments , including Semaglutide , belong to a class of drugs called GLP-1 agents. Primarily intended for controlling diabetes mellitus , they operate by helping the body to secrete more the hormone insulin and curbing excessive blood sugar levels. Additionally , their ability to promote slimming has resulted to substantial attenti